<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02045550</url>
  </required_header>
  <id_info>
    <org_study_id>HeHe02</org_study_id>
    <nct_id>NCT02045550</nct_id>
  </id_info>
  <brief_title>Tolerance and Effect of a Prophylactical Treatment With Ivy Leaves Dry Extract in Recurrent Wheezy Bronchitis</brief_title>
  <official_title>Tolerance and Effect of a Prophylactical Treatment With a Cough Medicine Con-taining Ivy Leaves Dry Extract in Children With Recurrent Wheezy Bronchitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Technische Universität Dresden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Technische Universität Dresden</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of a prophylactical therapy with a cough medicine containing ivy
      leaves dry extract on the frequency of recurrent wheezy bronchitis in toddlers, on the
      duration of the bronchitis episodes, on the severity and the additional drug demand. A
      prolonged asymptomatic episode between each wheezy bronchitis due to the therapy is assumed.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">August 2015</completion_date>
  <primary_completion_date type="Anticipated">August 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the time to event (next bronchitis episode) rate during and after treatment period</measure>
    <time_frame>three months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>days and percentage of days without bronchitis during and after treatment period</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>days and percentage of days without bronchitis during treatment period</measure>
    <time_frame>three months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Acute Wheezy Bronchitis</condition>
  <condition>Recurrent Bronchitis</condition>
  <arm_group>
    <arm_group_label>Placebo Syrup</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo Syrup 2.5 ml twice daily for 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prospan Syrup</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Prospan Syrup 2.5 ml twice daily for 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prospan Syrup</intervention_name>
    <description>2.5 ml twice daily for 4 weeks</description>
    <arm_group_label>Prospan Syrup</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Medical diagnosis of ≥3 episodes of wheezy bronchitis within the pre-vious 12 months

          2. Children aged from 1 to 3 years (girls and boys)

          3. Signed Informed Consent of the legal guardians to participate in the trial after
             written and verbal briefing by the Investigator

          4. No allergic sensitization

          5. Allowance to contact the familys pediatrician for medical history of wheezy bronchitis
             episodes

        Exclusion Criteria:

          1. Anamnestically known intolerance/allergy to one of the drugs applied or to their
             ingredients or to drugs of similar chemical structure

          2. Participation of the patient in another clinical trial within the last four weeks
             before enrollment in this trial

          3. Evidence suggesting that the patient or their legal representative is not likely to
             follow the trial protocol (e.g. lacking compliance)

          4. Inability to document the symptoms in a symptom log book or ques-tionnaire; inability
             to take the trial medication properly

          5. Any regular therapy except Vitamin D or Fluoride

          6. Chronic illnesses of different aetiology

          7. Premature birth or diagnosis of bronchopulmonary dysplasia

          8. Gastro-oesophageal reflux

          9. Hereditary fructose intolerance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Vogelberg, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Technische Universität Dresden</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Vogelberg, MD PhD</last_name>
    <phone>0049351458</phone>
    <phone_ext>5699</phone_ext>
    <email>christian.vogelberg@uniklinikum-dresden.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinikum Carl Gustav Carus, Klinik und Poliklinik für Kinder- und Jugendmedizin</name>
      <address>
        <city>Dresden</city>
        <state>Saxonia</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Vogelberg, MD PhD</last_name>
      <phone>0049351458</phone>
      <phone_ext>2073</phone_ext>
      <email>christian.vogelberg@uniklinikum-dresden.de</email>
    </contact>
    <investigator>
      <last_name>Sabine Zeil, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christian Vogelberg, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2014</study_first_submitted>
  <study_first_submitted_qc>January 23, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2014</study_first_posted>
  <last_update_submitted>January 23, 2014</last_update_submitted>
  <last_update_submitted_qc>January 23, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchitis</mesh_term>
    <mesh_term>Acute Disease</mesh_term>
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

